Watchlist Price Alert

Bellerophon Therapeutics ... (BLPH)

NASDAQ: BLPH · Real-Time Price · USD

0.01

-0.01 (-47.37%)

At close: Dec 18, 2024, 5:51 PM

Bellerophon Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	4.38M	10.57M	15.17M	6.92M	11.32M	16.33M	20M	24.74M	28.71M	34.3M	39.67M	47.56M	53.97M	59.31M	8.6M	9.87M	12.84M	16.8M	20.68M	16.64M	19.55M	23.4M	28.35M	28.82M	32.28M	10.97M	13.54M	14.45M	3.93M	1.3M	1.27M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	998K	2.5M	2.99M	3M	3.18M	3.9M	3.11M	5.57M	7.23M	11.92M	16.09M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	300K	300K	300K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	186K	186K	186K	186K	186K	186K	186K	486K	486K	486K	477K	300K	300K	300K	300K	300K	300K	300K	344K	176K	190K	204K	359K	769K	1.22M	1.8M	3.76M	6.05M	6.44M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	597K	670K	599K	234K	404K	403K	103K	103K	103K	103K	103K	103K	103K	103K	103K	103K	102K	825K	948K	650K	1.99M	2.9M	3.42M	3.36M	7.11M	5.51M	6.59M	6.33M	6.37M	5.41M	5.73M
Total Current Assets	4.98M	11.24M	15.77M	7.56M	12.06M	16.99M	20.52M	25.46M	29.71M	35.29M	40.22M	48.08M	54.71M	60.31M	9.05M	10.38M	13.65M	17.73M	21.73M	17.4M	22.54M	28.79M	34.76M	35.58M	39.4M	20.38M	23.24M	26.5M	17.52M	18.63M	23.09M
Property-Plant & Equipment	n/a	n/a	9K	186K	363K	556K	743K	930K	1.11M	1.3M	1.49M	1.67M	1.86M	2.04M	2.23M	2.43M	2.66M	2.55M	2.77M	664K	755K	845K	935K	1.03M	1.12M	1.21M	1.3M	1.4M	1.5M	1.6M	1.7M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	195K	372K	549K	742K	1.23M	1.42M	1.6M	1.79M	1.97M	2.16M	2.33M	2.34M	2.53M	2.73M	2.96M	2.85M	3.06M	964K	1.1M	1.02M	1.13M	1.23M	1.48M	1.98M	2.52M	3.2M	5.26M	7.65M	8.14M
Total Assets	4.98M	11.24M	15.97M	7.93M	12.61M	17.73M	21.75M	26.88M	31.32M	37.08M	42.19M	50.24M	57.04M	62.65M	11.58M	13.11M	16.61M	20.58M	24.79M	18.36M	23.64M	29.82M	35.89M	36.81M	40.87M	22.36M	25.76M	29.7M	22.78M	26.28M	31.22M
Account Payables	612K	1.89M	1.07M	1.23M	1.52M	2.01M	2.19M	1.19M	1.28M	2.48M	3.81M	3.73M	3.82M	2.84M	2.22M	3.11M	2.26M	2.82M	2.64M	2.75M	4.37M	4.06M	4.59M	3.85M	2.75M	2.83M	3.94M	2.81M	2.23M	2.02M	641K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	8K	n/a	396K	586K	765K	n/a	740K	728K	716K	n/a	692K	680K	669K	n/a	647K	556K	547K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	-8K	n/a	-396K	-586K	-765K	n/a	-740K	-728K	-716K	n/a	-692K	-680K	-669K	n/a	-647K	3.33M	4.07M	4.78M	4.7M	4.98M	3.8M	3.23M	3.66M	2.66M	2.12M	3.69M	2.55M	4.19M	6.68M
Total Current Liabilities	1.26M	5.62M	5.36M	5.4M	5.18M	5.45M	5.57M	5.05M	5.13M	6.23M	8.09M	10.43M	8.99M	6.58M	6.78M	7.58M	6.98M	6.71M	7.26M	7.54M	9.07M	9.04M	8.4M	7.08M	6.41M	5.49M	6.06M	6.5M	4.79M	6.21M	7.32M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.74M	1.88M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	1K	1K	1K	1K	1K	168K	204K	601K	1.04M	1.36M	1.17M	274K	452K	667K	5.35M	6.96M	10.64M	28.55M	25.27M	32.33M	18.78M	17.65M	18.9M	5.21M	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	4.29M	1.43M	1K	1K	9K	204K	397K	754K	977K	1.56M	2.18M	2.67M	2.66M	1.93M	2.28M	2.41M	7.23M	6.96M	10.64M	28.55M	25.27M	32.33M	18.78M	17.65M	18.9M	5.21M	n/a	n/a	n/a
Total Liabilities	1.26M	5.62M	5.36M	5.4M	5.18M	5.45M	5.58M	5.26M	5.52M	6.98M	9.06M	11.99M	11.17M	9.25M	9.43M	9.52M	9.26M	9.12M	14.49M	14.5M	19.71M	37.59M	33.67M	39.4M	25.2M	23.14M	24.96M	11.71M	4.79M	6.21M	7.32M
Total Debt	n/a	n/a	8K	203K	396K	586K	773K	955K	1.14M	1.31M	1.49M	1.66M	1.83M	1.99M	2.16M	2.32M	2.48M	2.29M	2.43M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	122K	122K	104K	96K	95K	95K	95K	95K	95K	95K	95K	95K	95K	95K	49K	46K	689K	689K	689K	587K	587K	578K	574K	569K	550K	352K	330K	317K	145K	139K	135K
Retained Earnings	-256.31M	-254.39M	-249.26M	-252.08M	-247.06M	-241.99M	-237.89M	-232.25M	-227.97M	-223.34M	-219.95M	-214.49M	-206.49M	-198.55M	-194.73M	-189.76M	-185.68M	-181.4M	-177.29M	-176.5M	-175.58M	-186.69M	-175.21M	-179.31M	-155.15M	-147.56M	-143.63M	-124.49M	-117.07M	-112.87M	-107.74M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.21M	n/a	n/a	n/a	n/a	-1K	-3K	-5K	-4K	n/a	n/a	n/a	n/a	-1K	2K	2K
Shareholders Equity	3.72M	5.62M	10.6M	2.53M	7.43M	12.28M	16.17M	21.62M	25.79M	30.1M	33.13M	38.25M	45.87M	53.4M	2.15M	3.59M	7.35M	11.46M	10.3M	3.86M	3.93M	-7.78M	2.22M	-2.59M	15.67M	-787K	800K	17.99M	18M	20.07M	23.9M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	300K	300K	300K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	998K	2.5M	2.99M	3M	3.18M	3.9M	3.11M	5.57M	7.23M	11.92M	16.09M